Cargando…

Simultaneously Screening for Liver Steatosis and Fibrosis in Romanian Type 2 Diabetes Mellitus Patients Using Vibration-Controlled Transient Elastography with Controlled Attenuation Parameter

Non-alcoholic fatty liver disease (NAFLD) is a common finding among patients with type 2 diabetes mellitus (T2DM). Between NAFLD and T2DM exist a bidirectional relationship. Patients with T2DM are at high risk for NAFLD, and evidence suggests that T2DM is linked to progressive NAFLD and poor liver o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trifan, Anca, Stratina, Ermina, Nastasa, Robert, Rotaru, Adrian, Stafie, Remus, Zenovia, Sebastian, Huiban, Laura, Sfarti, Catalin, Cojocariu, Camelia, Cuciureanu, Tudor, Muzica, Cristina, Chiriac, Stefan, Girleanu, Irina, Singeap, Ana-Maria, Stanciu, Carol
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322355/ https://www.ncbi.nlm.nih.gov/pubmed/35885657 http://dx.doi.org/10.3390/diagnostics12071753

Ejemplares similares

Screening for Liver Steatosis and Fibrosis in Patients with Inflammatory Bowel Disease Using Vibration Controlled Transient Elastography with Controlled Attenuation Parameter
por: Trifan, Anca, et al.
Publicado: (2022)

High prevalence of liver fibrosis among general population: a Romanian population-based study
por: Trifan, Anca, et al.
Publicado: (2023)

Changes in Liver Steatosis Using Controlled Attenuation Parameter among Patients with Chronic Hepatitis C Infection Treated with Direct-Acting Antivirals Therapy Who Achieved Sustained Virological Response
por: Trifan, Anca, et al.
Publicado: (2022)

The Prevalence of Liver Steatosis and Fibrosis Assessed by Vibration-Controlled Transient Elastography and Controlled Attenuation Parameter in Apparently Healthy Romanian Medical Students
por: Nastasa, Robert, et al.
Publicado: (2021)

Clinical and Laboratory Characteristics of Normal Weight and Obese Individuals with Non-Alcoholic Fatty Liver Disease
por: Trifan, Anca, et al.
Publicado: (2022)

Predictive Factors for the Prognosis of Alcoholic Liver Cirrhosis
por: Trifan, Anca, et al.
Publicado: (2022)

Changes in Components of Metabolic Syndrome after Antiviral Eradication in Hepatitis C Virus Infection
por: Trifan, Anca, et al.
Publicado: (2023)

Vibration-Controlled Transient Elastography and Controlled Attenuation Parameter for the Diagnosis of Liver Steatosis and Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
por: Zenovia, Sebastian, et al.
Publicado: (2021)

Impaired Intestinal Permeability Assessed by Confocal Laser Endomicroscopy—A New Potential Therapeutic Target in Inflammatory Bowel Disease
por: Chiriac, Stefan, et al.
Publicado: (2023)

The Role of Presepsin and Procalcitonin in Early Diagnosis of Bacterial Infections in Cirrhotic Patients with Acute-on-Chronic Liver Failure
por: Igna, Razvan, et al.
Publicado: (2022)

The Role of Presepsin in Diagnosing Infections in Patients with Liver Cirrhosis and Overt Hepatic Encephalopathy
por: Igna, Razvan, et al.
Publicado: (2022)

Anticoagulation for Atrial Fibrillation in Patients with Decompensated Liver Cirrhosis: Bold and Brave?
por: Gîrleanu, Irina, et al.
Publicado: (2023)

Association between Nonalcoholic Fatty Liver Disease and Endocrinopathies: Clinical Implications
por: Singeap, Ana-Maria, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases: The Heart of the Matter
por: Chiriac, Stefan, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: A Bidirectional Relationship
por: Muzica, Cristina M., et al.
Publicado: (2020)

Nonalcoholic Fatty Liver Disease-Related Chronic Kidney Disease
por: Cojocariu, Camelia, et al.
Publicado: (2020)

The Impact of the COVID-19 Pandemic on Gastrointestinal Endoscopy Activity in a Tertiary Care Center from Northeastern Romania
por: Chiriac, Stefan, et al.
Publicado: (2021)

Hepatitis C Virus Prevalence and Risk Factors in a Village in Northeastern Romania—A Population-Based Screening—The First Step to Viral Micro-Elimination
por: Huiban, Laura, et al.
Publicado: (2021)

The Risk of Clostridioides difficile Infection in Cirrhotic Patients Receiving Norfloxacin for Secondary Prophylaxis of Spontaneous Bacterial Peritonitis—A Real Life Cohort
por: Girleanu, Irina, et al.
Publicado: (2021)

Did the severe acute respiratory syndrome-coronavirus 2 pandemic cause an endemic Clostridium difficile infection?
por: Cojocariu, Camelia, et al.
Publicado: (2021)

Clinical Impact of Small Bowel Capsule Endoscopy in Obscure Gastrointestinal Bleeding
por: Singeap, Ana-Maria, et al.
Publicado: (2020)

Hepatocellular carcinoma after direct-acting antiviral hepatitis C virus therapy: A debate near the end
por: Muzica, Cristina Maria, et al.
Publicado: (2020)

Ischemic Heart Disease and Liver Cirrhosis: Adding Insult to Injury
por: Gîrleanu, Irina, et al.
Publicado: (2022)

Role of ammonia in predicting the outcome of patients with acute-on-chronic liver failure
por: Chiriac, Stefan, et al.
Publicado: (2021)

The Relation between Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis and Different Cannulation Techniques: The Experience of a High-Volume Center from North-Eastern Romania
por: Chiriac, Stefan, et al.
Publicado: (2023)

Idiopathic Cervical Esophageal Webs: A Case Report and Literature Review
por: Petrea, Oana Cristina, et al.
Publicado: (2020)

L3 Skeletal Muscle Index Dynamics in Patients with HCV-Related Compensated Cirrhosis Following Sustained Virological Response after Direct Acting Antiviral Treatment
por: Mihai, Florin, et al.
Publicado: (2021)

Ulcerated intussuscepted jejunal lipoma-uncommon cause of obscure gastrointestinal bleeding: A case report
por: Cuciureanu, Tudor, et al.
Publicado: (2019)

Liver Remodeling on CT Examination in Patients with HCV Compensated Cirrhosis Who Achieved Sustained Virological Response after Direct-Acting Antivirals Treatment
por: Mihai, Florin, et al.
Publicado: (2020)

Chronic hepatitis C virus infection: a new modifiable cardio-metabolic risk factor?
por: CUCIUREANU, TUDOR, et al.
Publicado: (2017)

Natural Course of Nonmalignant Partial Portal Vein Thrombosis in Cirrhotic Patients
por: Girleanu, Irina, et al.
Publicado: (2014)

Systemic Oxidative Stress Markers in Cirrhotic Patients with Hepatic Encephalopathy: Possible Connections with Systemic Ammoniemia
por: Sfarti, Cătălin, et al.
Publicado: (2020)

Portal vein thrombosis in cirrhotic patients - it is always the small pieces that make the big picture
por: Gîrleanu, Irina, et al.
Publicado: (2018)

Coagulation Dysfunctions in Non-Alcoholic Fatty Liver Disease—Oxidative Stress and Inflammation Relevance
por: Robea, Madalina Andreea, et al.
Publicado: (2023)

Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis
por: Trifan, Anca, et al.
Publicado: (2017)

Splanchnic Vein Thrombosis in Cirrhosis − Areas Still in the Shadow
por: Gîrleanu, Irina, et al.
Publicado: (2018)

Increased liver stiffness in extrahepatic cholestasis caused by choledocholithiasis
por: Trifan, Anca, et al.
Publicado: (2011)

Duodenal large-cell neuroendocrine carcinoma as unusual cause of acute pancreatitis
por: Zenovia, Sebastian, et al.
Publicado: (2021)

Nonalcoholic steatohepatitis: A scientometric analysis of publications during 1980–2018
por: Trifan, Anca, et al.
Publicado: (2019)

Efficacy and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with ribavirin for the treatment of HCV genotype 1b compensated cirrhosis in patients aged 70 years or older
por: Trifan, Anca, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_t73lavbbj6ij7j8nkf0qunppe4